June 24, 2025
| Today’s news and insights for medtech leaders
NOTE FROM THE EDITOR
We have updated the headline and text of our story on Dexcom's recall of CGM receivers to reflect new information from the Food and Drug Administration on the number of devices affected by the recall. The updated story is below.
|
Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared updates on its implantable glucose sensors.
|
The move to block Chinese medical device companies from bidding on EU government contracts is intended to defend EU-based businesses from unfair treatment in China, the European Commission said.
|
The recall affects 15 Carestation models and more than 14,000 individual devices.
|
UPDATED
Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports Dexcom received.
|
Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X products.
|
The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since receiving an expanded indication, and shared an update on plans for a closed-loop system.
|
From Our Library
Playbook
Custom content for Medrio
|
Playbook
Custom content for Altium
|
Playbook
Custom content for Medrio
|
View all resources
What We're Reading
Reuters
|
Healthcare Dive
| |